SavedAdd your journal

Journals / ARTEMİS / 2004 / Cilt: 5 - Sayı: 2

Intravenous leiomyomatosis: to assess the management protocol under guide of a case report

İntravenöz leiomyomatozis: Bir olgu sunumu nedeniyle izlem protokolünün irdelenmesi

Gazi YILDIRIM
Pınar ÇİLESİZ
Sadiye EREN
Semih TUĞRUL
Gözde KIR
Journal
ARTEMİS
Pages
147–149
Publication Date
2022-10-11
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

This case is reported, because the probability of recurrence of this neoplasm.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Intravenous leiomyomatosis is a rare benign tumor, characterized smooth muscle cell proliferation into the veins outside of leimyoma.
📊
Key Findings & Data:Usually, this condition is grossly determined as wormlike plags within the blood vessels.
💡
Conclusion & Impact:This case is reported, because the probability of recurrence of this neoplasm.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Intravenous leiomyomatosis is a rare benign tumor, characterized smooth muscle cell proliferation into the veins outside of leimyoma. Usually, this condition is grossly determined as wormlike plags within the blood vessels. The treatment and management of this conditions require special care. This case is reported, because the probability of recurrence of this neoplasm.

Özet

İntravenöz leiomyomatozis nadir bir benign tümör olup, leiomyomun dışındaki alanlarda intravasküler benign düz kas proliferasyonu ile karakterizedir. Bu durum çoğu kez gross olarak damarlar içinde solucanvari tıkaçlar olarak izlenebilir. Tekrarlama olasılığından dolayı tedavi ve izlemeyi özellik gerektiren bu patolojiyi tekrar gözden geçirmek için bu olgu sunulmuştur.

🔖

Cite This Article

YILDIRIM, G., ÇİLESİZ, P., EREN, S., TUĞRUL, S., KIR, G. (2022). Intravenous leiomyomatosis: to assess the management protocol under guide of a case report. ARTEMİS, Cilt: 5 - Sayı: 2, 147–149. https://ajindex.com/articles/449492

References (8)

  1. Grella L, Arnold TA, Kvileklav KH, Giron F. Intravenous leiomyomatosis. Vasc Surg 1994;20:987-994
  2. Clement BP. Intravenous leiomyomatosis of the uterus. Pathol Annu 1988;23:153-183
  3. Edwards DR, Peacock JF. Intravenous leimyomatosis of the uterus: report of 2 cases. Obstet Gynecol 1966;27:176
  4. Rush DS, Tan JY, Baergen RN, Soslow RA. H-caldesmon; a novel smooth muscle-spesific antibody, distinguishes between cellular leiomyoma and endometrial stromal sarcoma. Am J Surg Pathol 2001;25:253-258
  5. Nucci MR, Connel JT, Huetter PC, Cviko A, Sun D, Quade BJ. H-caldesmon expression effectively distinguishes endometrial stromal tumors from uterine smooth muscle tumors. Am J Surg Pathol 2001;25:455-463
  6. Andrade LA, Torresan Rz, Sales JF Jr, Visentini R, De Souza GA. Intrave- nous leimyomatosis of the uterus. A report of three cases. Pathol Oncol Res 1998;4(1):44-47
  7. Arinami Y, Kodama S, Kase H, Tanaka K, Okazaki Maruyama Y. Successfull one-stage complete removal of an entire intravenous leimyomatosis in the hearth, vena cava, and uterus. Gynecol Oncol 1997;64:547-550
  8. Hayasaka K, Tanaka Y, Fujii M, Himi K, Negishi N. Intravenous leimyomatosis. J Comput Assist Tomogr 2000;24(1):83-85.